Optic Neuritis News and Research

RSS
Optic neuritis is a condition in which the optic nerve becomes inflamed and swollen, leading to an acute severe impairment of vision in the affected eye. The swelling may further lead to damage to the nerve fibers running through the nerve, causing permanent or temporary loss of vision in that eye. It is much more common in young female patients.
Escalation therapy for neuromyelitis attacks improves remission rates

Escalation therapy for neuromyelitis attacks improves remission rates

Multiple sclerosis relapse management: an interview with Gina Remington

Multiple sclerosis relapse management: an interview with Gina Remington

Children recover well from acute central nervous system demyelination

Children recover well from acute central nervous system demyelination

International consensus panel reviews new diagnostic criteria for neuromyelitis optica spectrum disorder

International consensus panel reviews new diagnostic criteria for neuromyelitis optica spectrum disorder

MedDay announces additional positive results from MD1003 Phase III trial in patients with progressive MS

MedDay announces additional positive results from MD1003 Phase III trial in patients with progressive MS

Amgen and Merck expand collaboration for Talimogene laherparepvec-KEYTRUDA combination study

Amgen and Merck expand collaboration for Talimogene laherparepvec-KEYTRUDA combination study

UCB sponsoring several presentations on Cimzia for Crohn's disease at DDW 2015

UCB sponsoring several presentations on Cimzia for Crohn's disease at DDW 2015

Two existing drugs may reverse damage caused by multiple sclerosis

Two existing drugs may reverse damage caused by multiple sclerosis

Study shows epilepsy drug can protect vision of MS patients

Study shows epilepsy drug can protect vision of MS patients

Quadrivalent HPV vaccine cleared of multiple sclerosis risk

Quadrivalent HPV vaccine cleared of multiple sclerosis risk

Yoga program for MS patients improves physical and mental well-being

Yoga program for MS patients improves physical and mental well-being

UCB, Dermira enter into licensing agreement for development, commercialization of Cimzia

UCB, Dermira enter into licensing agreement for development, commercialization of Cimzia

Caregivers selected to receive the 2013 Shire BRAVE Awards

Caregivers selected to receive the 2013 Shire BRAVE Awards

Glaucoma and cell death: an interview with Dr. Vivek Gupta

Glaucoma and cell death: an interview with Dr. Vivek Gupta

Plasma exchange is beneficial additive to optic neuritis treatment

Plasma exchange is beneficial additive to optic neuritis treatment

Questcor's H.P. Acthar Gel sNDA for infantile spasms receives FDA approval

Questcor's H.P. Acthar Gel sNDA for infantile spasms receives FDA approval

New studies supporting Teva Pharmaceutical Industries' CNS portfolio to be presented at AAN 2010

New studies supporting Teva Pharmaceutical Industries' CNS portfolio to be presented at AAN 2010

Stem cell treatment: A new hope for Multiple Sclerosis

Stem cell treatment: A new hope for Multiple Sclerosis

NMO patients are misdiagnosed with Multiple Sclerosis, says Mayo Clinic neurologist

NMO patients are misdiagnosed with Multiple Sclerosis, says Mayo Clinic neurologist

Optic nerve sheath meningioma patients can be cured using fractionated stereotactic radiotherapy

Optic nerve sheath meningioma patients can be cured using fractionated stereotactic radiotherapy